Blue Trust’s Teva Pharmaceutical Industries TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$96.1K Buy
2,427
+341
+16% +$12.2K ﹤0.01% 1018
2026
Q2
$70.7K Buy
2,086
+1,408
+208% +$46.9K ﹤0.01% 1190
2026
Q1
$20.4K Sell
678
-57
-8% -$1.83K ﹤0.01% 1640
2025
Q4
$22.9K Sell
735
-20
-3% -$493 ﹤0.01% 1640
2025
Q3
$15.3K Hold
755
– – ﹤0.01% 1744
2025
Q2
$12.7K Sell
755
-13
-2% -$210 ﹤0.01% 1820
2025
Q1
$11.8K Sell
768
-4,899
-86% -$87.5K ﹤0.01% 1824
2024
Q4
$125K Sell
5,667
-8,952
-61% -$163K ﹤0.01% 846
2024
Q3
$238K Buy
14,619
+4,185
+40% +$73.2K ﹤0.01% 782
2024
Q2
$147K Buy
10,434
+6,481
+164% +$100K ﹤0.01% 819
2024
Q1
$55.8K Sell
3,953
-588
-13% -$7.41K ﹤0.01% 877
2023
Q4
$46K Buy
4,541
+2,180
+92% +$20.4K ﹤0.01% 971
2023
Q3
$18K Sell
2,361
-421
-15% -$3.92K ﹤0.01% 1217
2023
Q2
$25K Buy
2,782
+520
+23% +$4.22K ﹤0.01% 969
2023
Q1
$21K Sell
2,262
-1,415
-38% -$14K ﹤0.01% 1348
2022
Q4
$30K Buy
3,677
+3,401
+1,232% +$29.7K ﹤0.01% 1135
2022
Q3
$2K Buy
276
+240
+667% +$2.12K ﹤0.01% 1835
2022
Q2
$0 Buy
+36
New +$314 ﹤0.01% 2006

Other funds holding TEVA

Blue Trust's TEVA Position: Q3 2026 in Review

Blue Trust increased its Teva Pharmaceutical Industries (TEVA) stake by 16% in Q3 2026, buying an estimated $12.2K and bringing the position to 2,427 shares worth $96.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1018.

Blue Trust first reported a position in TEVA in Q2 2022 and has held it in 18 quarters since. The position peaked at $238K in Q3 2024. 488 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

  • Blue Trust held 2,427 shares of Teva Pharmaceutical Industries worth $96.1K as of Q3 2026.
  • Blue Trust bought 341 Teva Pharmaceutical Industries shares in Q3 2026, an estimated $12.2K.
  • Teva Pharmaceutical Industries made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #1018 holding.
  • Blue Trust first reported a position in Teva Pharmaceutical Industries in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's Teva Pharmaceutical Industries position peaked at $238K in Q3 2024.
  • 488 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.